• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Psychedelics

Recent news which mentions Psychedelics

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
32 33 Next >
DEA Revisits Proposed Ban On Two Psychedelic Compounds: Researchers Disagree, Insist On Hearings
April 02, 2024
Tickers DEA NEWS
Tags Market News psychedelic compounds Psychedelics
From Benzinga
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
March 30, 2024
Tickers CMND CMPS CYBN FLHLF
Tags HUGE Psychedelic/Assisted Therapies Psychedelics
From Benzinga
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
March 29, 2024
Tickers ATAI CMND CMPS DRUG
Tags SILO IXHL LSDI
From Benzinga
Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline
March 29, 2024
Tickers ATAI CMPS
Tags Earnings Psychedelics Psychedelic/Assisted Therapies
From Benzinga
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
March 28, 2024
Tickers ATAI NEWS
Tags ATAI treatment/resistant depression Psychedelic/Assisted Therapies
From Benzinga
PharmAla's Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development
March 27, 2024
Tickers MDXXF
Tags MDXX class molecules Cannabis Global
From Benzinga
Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow
March 27, 2024
Tickers MNMD NEWS
Tags FDA News Exclusives
From Benzinga
Enveric Biosciences Optimistic On Q4 And Full-Year Results: 'Psychedelic-Inspired' Meds For Future Growth
March 27, 2024
Tickers ENVB
Tags Cannabis Benzinga financial results
From Benzinga
At 77, Cannabis Champion Dana Beal Fights Idaho Laws To Push Legalization In Hostile Territory
March 26, 2024
Tickers NEWS
Tags Ibogaine Don Wirtshafter Dana Beal
From Benzinga
Two Top Biotechs Forge MDMA Supply Deals For Clinical Research
March 26, 2024
Tickers MDXXF NEWS NUMIF OPTHF
Tags Market News Biotech Psychedelics Research
From Benzinga
Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions
March 25, 2024
Tickers NEWS NUMIF
Tags News MDMA Therapy FDA
From Benzinga
VA Calls For Amending Medical Marijuana Bill, Rejects Psychedelics Proposal
March 22, 2024
Tickers NEWS
Tags Psychedelics Reform VA Cannabis Cannabis
From Benzinga
Congress Discusses Remaining FY2024 Spending Bill With Provisions On Cannabis Sales And Psychedelic Clinical Trials
March 22, 2024
Tags Market News Psychedelics Research Psychedelics
From Benzinga
Psychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In Colorado
March 22, 2024
Tickers CCC IXHL
Tags Denver Natural Medicine Health Act Market News
From Benzinga
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
March 20, 2024
Tickers ATAI CMND CMPS CYBN
Tags Psychedelics Research PBM SILO
From Benzinga
Goodbye To Weed Posts In Colorado? Lawmakers Target Social Media Promotion Of Cannabis And Psychedelics
March 19, 2024
Tickers NEWS
Tags Dafna Michaelson Jenet SB24/158 Market News
From Benzinga
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap